Manufacturing

CDMO Sector Faces Challenges and Opportunities Amid 2024 Market Shifts
Management & Regulatory CDMO Sector Faces Challenges and Opportunities Amid 2024 Market Shifts

The Contract Development and Manufacturing Organization (CDMO) sector is navigating a landscape marked by significant changes and evolving trends. Gil Roth, President of the Pharma & Biopharma Outsourcing Association, provides a comprehensive analysis of the sector's current state and future

Advancing Inline Monitoring for Superior Bioreactor Performance
Biotech & Bioprocessing Advancing Inline Monitoring for Superior Bioreactor Performance

In the rapidly evolving landscape of biopharmaceutical manufacturing, capturing real-time data has become pivotal in optimizing bioreactor performance and producing high-quality products. Inline monitoring technologies are at the forefront of this transformation, offering real-time surveillance and

Telehealth Transforming Healthcare Access Through Strategic Investments
Management & Regulatory Telehealth Transforming Healthcare Access Through Strategic Investments

In recent years, the healthcare industry has experienced a paradigm shift due to the rapid advancement of telemedicine technologies and the strategic investments made by pharmaceutical, medical device, and digital therapeutics (DTx) companies. The surge in telehealth investments is primarily driven

Why is Rentschler Exiting the Cell and Gene Therapy Market?
Research & Development Why is Rentschler Exiting the Cell and Gene Therapy Market?

In a surprising move, Rentschler Biopharma announced its decision to withdraw from the cell and gene therapy (CGT) business at its Stevenage, UK facility, marking a significant shift in the company's strategic focus. This decision comes despite recent investments in building advanced capabilities

Can Gates' Influence Improve Global Health and Biologics Manufacturing?
Management & Regulatory Can Gates' Influence Improve Global Health and Biologics Manufacturing?

Bill Gates' significant role in global health policy, especially through the Bill & Melinda Gates Foundation, raises critical questions about philanthropy's impact on international health and the sustainability of biologics manufacturing. The Foundation is known for its substantial contributions to

Transformative Trends in Biopharma: Preparing for 2025 and Beyond
Management & Regulatory Transformative Trends in Biopharma: Preparing for 2025 and Beyond

The biopharma industry stands at a transformative juncture as it reflects on the achievements of the past year and anticipates the evolving client requirements that will shape 2025 and beyond. Key insights from Subodh Deshmukh, CEO of Aragen Bioscience, highlight the crucial areas of focus for

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later